AP
CLX icon

Advisor Partners’s Clorox CLX Stock Holding History

Advisor Partners’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$918K Buy
6,514
+1,583
+32% +$226K 0.06% 313
2022
Q1 		$686K Sell
4,931
-2,451
-33% -$376K 0.04% 419
2021
Q4 		$1.29M Buy
7,382
+584
+9% +$97.4K 0.08% 247
2021
Q3 		$1.13M Sell
6,798
-548
-7% -$94.4K 0.08% 249
2021
Q2 		$1.32M Sell
7,346
-656
-8% -$120K 0.09% 225
2021
Q1 		$1.54M Sell
8,002
-241
-3% -$46.4K 0.11% 183
2020
Q4 		$1.66M Sell
8,243
-240
-3% -$49.7K 0.13% 161
2020
Q3 		$1.78M Sell
8,483
-238
-3% -$53K 0.15% 134
2020
Q2 		$1.91M Sell
8,721
-257
-3% -$51.3K 0.18% 115
2020
Q1 		$1.55M Buy
8,978
+3,296
+58% +$545K 0.19% 115
2019
Q4 		$890K Buy
5,682
+685
+14% +$102K 0.09% 230
2019
Q3 		$759K Buy
4,997
+217
+5% +$34.3K 0.09% 236
2019
Q2 		$732K Sell
4,780
-43
-0.9% -$6.57K 0.09% 226
2019
Q1 		$774K Sell
4,823
-425
-8% -$65.9K 0.1% 206
2018
Q4 		$809K Buy
5,248
+499
+11% +$77.7K 0.13% 174
2018
Q3 		$714K Buy
4,749
+577
+14% +$82K 0.1% 215
2018
Q2 		$564K Buy
4,172
+408
+11% +$50.4K 0.1% 251
2018
Q1 		$501K Buy
3,764
+258
+7% +$34.7K 0.09% 263
2017
Q4 		$504K Sell
3,506
-396
-10% -$53.9K 0.09% 266
2017
Q3 		$515K Buy
3,902
+816
+26% +$110K 0.1% 213
2017
Q2 		$411K Buy
3,086
+341
+12% +$46K 0.1% 263
2017
Q1 		$370K Buy
2,745
+375
+16% +$48.6K 0.1% 265
2016
Q4 		$284K Buy
2,370
+330
+16% +$38.9K 0.09% 284
2016
Q3 		$255K Sell
2,040
-47
-2% -$6.16K 0.09% 298
2016
Q2 		$289K Buy
2,087
+87
+4% +$11.3K 0.1% 238
2016
Q1 		$252K Sell
2,000
-118
-6% -$15K 0.09% 258
2015
Q4 		$269K Buy
2,118
+43
+2% +$5.34K 0.09% 229
2015
Q3 		$240K Buy
+2,075
New +$233K 0.1% 246

Other funds holding CLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Advisor Partners's CLX Position: Q2 2022 in Review

Advisor Partners increased its Clorox (CLX) stake by 32% in Q2 2022, buying an estimated $226K and bringing the position to 6,514 shares worth $918K. The position accounts for 0.06% of the portfolio, ranked #313.

Advisor Partners first reported a position in CLX in Q3 2015 and has held it in 28 quarters since. The position peaked at $1.91M in Q2 2020. 1,081 funds tracked by Wall St. Rank hold CLX as of Q2 2022.

  • Advisor Partners held 6,514 shares of Clorox worth $918K as of Q2 2022.
  • Advisor Partners bought 1,583 Clorox shares in Q2 2022, an estimated $226K.
  • Clorox made up 0.06% of Advisor Partners's portfolio in Q2 2022, its #313 holding.
  • Advisor Partners first reported a position in Clorox in Q3 2015 and has held it in 28 quarters since.
  • Advisor Partners's Clorox position peaked at $1.91M in Q2 2020.
  • 1,081 funds tracked by Wall St. Rank held Clorox as of Q2 2022.

Based on Advisor Partners's 13F filing for Q2 2022, filed 11 Aug 2022.